Chimerix

Clinical Advisory Board

Michael Boeckh, M.D.

Professor of Medicine, University of Washington

Michael Boeckh is a full member of the Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Research Center and Professor of Medicine at the University of Washington in Seattle. Dr. Boeckh is a member of University of Washington Physicians , a not-for-profit group practice of physician specialists caring for patients at various sites in Seattle. His clinical area of expertise lie in infections in the immunocompromised host with areas of particular interest in diagnosis, prevention and treatment of CMV, VZV, BK virus, adenovirus and respiratory virus infections. Dr. Boeckh's research projects focus on aspects of cytomegalovirus and respiratory viruses in transplant recipients, as well as the genetic basis of host susceptibility to outcome of infectious complications after transplantation. He has published more than 150 peer reviewed articles and numerous review articles and book chapters in the field of transplant infectious diseases.

John Gnann Jr., M.D.

Professor of Medicine and Microbiology, University of Alabama at Birmingham

John Gnann is a professor of medicine and microbiology in the division of infectious diseases at the University of Alabama at Birmingham. Dr. Gnann is currently the protocol hair for a multicenter study of surveillance of acyclovir resistant HSV sponsored by the CDC, providing ongoing surveillance for acyclovir resistant HSV isolates from AIDS patients, as well as epidemiological data and in vitro characterization of resistant isolates. His research interests include clinical trials of antiviral therapies, mechanisms of viral resistance to antiviral drugs and opportunistic viral infections. Dr. Gnann is a co-investigator for the National Institute of Allergy and Infectious Diseases collaborative antiviral study group and currently has ongoing clinical trials studying the efficacy of varicella zoster vaccine in limiting the incidence of herpes zoster in older individuals as well as neuraminadase inhibitors in the prevention and treatment of influenza and the treatment of herpes simplex encephalitis in adults. He also plays an active role in a variety of clinical research projects that are both federally and industry, including an NIAID Collaborative Antiviral Study Group, a shingles prevention study, a study of surveillance for acyclovir resistant herpes simplex virus and industry sponsored clinical studies of antiviral drugs or viral diagnostics. Dr. Gnann received his medical degree from Duke University School of Medicine.

Raymund R. Razonable, M.D.

Associate Professor of Medicine, Mayo Clinic College of Medicine in Rochester

Raymund R Razonable is the associate chair for faculty development and diversity in the division of infectious diseases, the chair of the transplant infectious diseases program, and an associate professor of medicine at the College of Medicine at the Mayo Clinic in Rochester, Minnesota. Dr. Razonable’s clinical and research interests are centered on transplant infections. He has published over 100 original and review articles, book chapters, and other manuscripts in the field of infectious diseases. Dr. Razonable has served as a reviewer for over 20 medical and scientific journals and is currently editor of Transplant Infectious Diseases, member of the Editorial Advisory Board of the Journal of Infectious Diseases and has served in panels that develop national and international guidelines for the management of infections. Dr. Razonable is currently a member of the American Society for Microbiology, Infectious Disease Society of America, Immunocompromised Host Society, the Transplantation Society, and the American Society of Transplantation.